Protection against Myocardial Ischemia-Reperfusion Injury at Onset of Type 2 Diabetes in Zucker Diabetic Fatty Rats Is Associated with Altered Glucose Oxidation

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Povlsen, Jonas Agerlund ^a,b   Løfgren, Bo ^a,b   Dalgas, Christian ^a,b   Birkler, Rune Isak Dupont ^b   Johannsen, Mogens ^b   Støttrup, Nicolaj Brejnholt ^a,b   Bøtker, Hans Erik ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CITRIC ACID CYCLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; GLYCOLYSIS; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HETEROZYGOTE; ISOLATED HEART; KINETICS; MALE; METABOLOMICS; MICRODIALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; REPERFUSION INJURY; ZUCKER DIABETIC FATTY RAT;

ANIMALS; ASPARTIC ACID; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; GLUCOSE; HEART FUNCTION TESTS; HEMODYNAMICS; MALATES; MALE; MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OXIDATION-REDUCTION; RATS; RATS, ZUCKER; RECOVERY OF FUNCTION;

EID: 84877961256     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064093     Document Type: Article

References (60)

1. Ferdinandy P, Schulz R, Baxter GF, (2007) Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 59: 418-458 doi:10.1124/pr.107.06002.
2. Bøtker HE, Kharbanda R, Schmidt MR, Bøttcher M, Kaltoft AK, et al. (2010) Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 375: 727-734 doi:10.1016/S0140-6736(09)62001-8.
3. Jensen RV, Støttrup NB, Kristiansen SB, Bøtker HE, (2012) Release of a humoral circulating cardioprotective factor by remote ischemic preconditioning is dependent on preserved neural pathways in diabetic patients. Basic Res Cardiol 107: 285 doi:10.1007/s00395-012-0285-1.
4. Chen Q, Hoppel CL, Lesnefsky EJ, (2006) Blockade of electron transport before cardiac ischemia with the reversible inhibitor amobarbital protects rat heart mitochondria. J Pharmacol Exp Ther 316: 200-207 doi:10.1124/jpet.105.091702.
5. Burwell LS, Nadtochiy SM, Brookes PS, (2009) Cardioprotection by metabolic shut-down and gradual wake-up. J Mol Cell Cardiol 46: 804-810 doi:10.1016/j.yjmcc.2009.02.026.
6. Yellon DM, Hausenloy DJ, (2007) Myocardial reperfusion injury. N Engl J Med 357: 1121-1135 doi:10.1056/NEJMra071667.
7. Vogt AM, Poolman M, Ackermann C, Yildiz M, Schoels W, et al. (2002) Regulation of glycolytic flux in ischemic preconditioning. A study employing metabolic control analysis. J Biol Chem 277: 24411-24419 doi:10.1074/jbc.M201138200.
8. Lowell BB, Shulman GI, (2005) Mitochondrial dysfunction and type 2 diabetes. Science 307: 384-387 doi:10.1126/science.1104343.
9. Støttrup NB, Løfgren B, Birkler RD, Nielsen JM, Wang L, et al. (2010) Inhibition of the malate-aspartate shuttle by pre-ischaemic aminooxyacetate loading of the heart induces cardioprotection. Cardiovasc Res 88: 257-266 doi:10.1093/cvr/cvq205.
10. Nielsen TT, Støttrup NB, Løfgren B, Bøtker HE, (2011) Metabolic fingerprint of ischaemic cardioprotection: importance of the malate-aspartate shuttle. Cardiovasc Res 91: 382-391 doi:10.1093/cvr/cvr051.
11. Dalgas C, Povlsen JA, Løfgren B, Erichsen SB, Bøtker HE, (2012) Effects of fatty acids on cardioprotection by pre-ischaemic inhibition of the malate-aspartate shuttle. Clin Exp Pharmacol Physiol 39: 878-885 doi:10.1111/j.1440-1681.2012.05749.x.
12. Contreras L, Gomez-Puertas P, Iijima M, Kobayashi K, Saheki T, et al. (2007) Ca2+ Activation kinetics of the two aspartate-glutamate mitochondrial carriers, aralar and citrin: role in the heart malate-aspartate NADH shuttle. J Biol Chem 282: 7098-7106 doi:10.1074/jbc.M610491200.
13. Palmieri L, Pardo B, Lasorsa FM, del Arco A, Kobayashi K, et al. (2001) Citrin and aralar1 are Ca(2+)-stimulated aspartate/glutamate transporters in mitochondria. EMBO J 20: 5060-5069 doi:10.1093/emboj/20.18.5060.
14. Rubi B, Del Arco A, Bartley C, Satrústegui J, Maechler P, (2004) The malate-aspartate NADH shuttle member Aralar1 determines glucose metabolic fate, mitochondrial activity, and insulin secretion in beta cells. J Biol Chem 279: 55659-55666 doi:10.1074/jbc.M409303200.
15. Ralphe JC, Bedell K, Segar JL, Scholz TD, (2005) Correlation between myocardial malate/aspartate shuttle activity and EAAT1 protein expression in hyper- and hypothyroidism. Am J Physiol Heart Circ Physiol 288: H2521-H2526 doi:10.1152/ajpheart.00991.2004.
16. Povlsen JA, Løfgren B, Rasmussen LE, Nielsen JM, Nørregaard R, et al. (2009) Cardioprotective effect of L-glutamate in obese type 2 diabetic Zucker fatty rats. Clin Exp Pharmacol Physiol 36: 892-898 doi:10.1111/j.1440-1681.2009.05166.x.
17. Løfgren B, Povlsen JA, Rasmussen LE, Støttrup NB, Solskov L, et al. (2010) Amino acid transamination is crucial for ischaemic cardioprotection in normal and preconditioned isolated rat hearts-focus on L-glutamate. Exp Physiol 95: 140-152 doi:10.1113/expphysiol.2009.049452.
18. Birkler RID, Støttrup NB, Hermannson S, Nielsen TT, Gregersen N, et al. (2010) A UPLC-MS/MS application for profiling of intermediary energy metabolites in microdialysis samples-a method for high-throughput. J Pharm Biomed Anal 53: 983-990 doi:10.1016/j.jpba.2010.06.005.
19. Bolukoglu H, Goodwin GW, Guthrie PH, Carmical SG, Chen TM, et al. (1996) Metabolic fate of glucose in reversible low-flow ischemia of the isolated working rat heart. Am J Physiol 270: H817-H826.
20. Katz J, Dunn A, (1967) Glucose-2-t as a tracer for glucose metabolism. Biochemistry 6: 1-5.
21. Doenst T, Taegtmeyer H, (2000) Kinetic differences and similarities among 3 tracers of myocardial glucose uptake. J Nucl Med 41: 488-492.
22. Neely JR, Denton RM, England PJ, Randle PJ, (1972) The effects of increased heart work on the tricarboxylate cycle and its interactions with glycolysis in the perfused rat heart. Biochem J 128: 147-159.
23. Bøtker HE, Randsbaek F, Hansen SB, Thomassen A, Nielsen TT, (1995) Superiority of acid extractable glycogen for detection of metabolic changes during myocardial ischaemia. J Mol Cell Cardiol 27: 1325-1332.
24. Xu G, Takashi E, Kudo M, Ishiwata T, Naito Z, (2004) Contradictory effects of short- and long-term hyperglycemias on ischemic injury of myocardium via intracellular signaling pathway. Exp Mol Pathol 76: 57-65.
25. Wang P, Chatham JC, (2004) Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart. Am J Physiol Endocrinol Metab 286: E725-E736 doi:10.1152/ajpendo.00295.2003.
26. Tosaki A, Engelman DT, Engelman RM, Das DK, (1996) The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts. Cardiovasc Res 31: 526-536.
27. Ravingerová T, Neckár J, Kolár F, (2003) Ischemic tolerance of rat hearts in acute and chronic phases of experimental diabetes. Mol Cell Biochem 249: 167-174.
28. Balakumar P, Sharma NK, (2012) Healing the diabetic heart: does myocardial preconditioning work? Cell Signal 24: 53-59 doi:10.1016/j.cellsig.2011.09.007.
29. Baynes J, Murray DB, (2009) Cardiac and renal function are progressively impaired with aging in Zucker diabetic fatty type II diabetic rats. Oxid Med Cell Longev 2: 328-334 doi:10.4161/oxim.2.5.9831.
30. Fredersdorf S, Thumann C, Ulucan C, Griese DP, Luchner A, et al. (2004) Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats. Cardiovasc Pathol 13: 11-19 doi:10.1016/S1054-8807(03)00109-1.
31. Kupai K, Csonka C, Fekete V, Odendaal L, van Rooyen J, et al. (2009) Cholesterol diet-induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite. Am J Physiol Heart Circ Physiol 297: H1729-H1735 doi:10.1152/ajpheart.00484.2009.
32. Ungi I, Ungi T, Ruzsa Z, Nagy E, Zimmermann Z, et al. (2005) Hypercholesterolemia attenuates the anti-ischemic effect of preconditioning during coronary angioplasty. Chest 128: 1623-1628 doi:10.1378/chest.128.3.1623.
33. Speechly-Dick ME, Baxter GF, Yellon DM, (1994) Ischaemic preconditioning protects hypertrophied myocardium. Cardiovasc Res 28: 1025-1029.
34. Ebrahim Z, Yellon DM, Baxter GF, (2007) Attenuated cardioprotective response to bradykinin, but not classical ischaemic preconditioning, in DOCA-salt hypertensive left ventricular hypertrophy. Pharmacol Res 55: 42-48 doi:10.1016/j.phrs.2006.10.004.
35. Byrne CJ, McCafferty K, Kieswich J, Harwood S, Andrikopoulos P, et al. (2012) Ischemic conditioning protects the uremic heart in a rodent model of myocardial infarction. Circulation 125: 1256-1265 doi:10.1161/CIRCULATIONAHA.111.055392.
36. Kocsis GF, Sárközy M, Bencsik P, Pipicz M, Varga ZV, et al. (2012) Preconditioning protects the heart in a prolonged uremic condition. Am J Physiol Heart Circ Physiol 303: H1229-H1236 doi:10.1152/ajpheart.00379.2012.
37. Chatham JC, Marchase RB, (2010) The role of protein O-linked beta-N-acetylglucosamine in mediating cardiac stress responses. Biochim Biophys Acta 1800: 57-66 doi:10.1016/j.bbagen.2009.07.004.
38. Chen H, Shen W-L, Wang X-H, Chen H-Z, Gu J-Z, et al. (2006) Paradoxically enhanced heart tolerance to ischaemia in type 1 diabetes and role of increased osmolarity. Clin Exp Pharmacol Physiol 33: 910-916 doi:10.1111/j.1440-1681.2006.04463.x.
39. Naito Z, Takashi E, Xu G, Ishiwata T, Teduka K, et al. (2003) Different influences of hyperglycemic duration on phosphorylated extracellular signal-regulated kinase 1/2 in rat heart. Exp Mol Pathol 74: 23-32.
40. Oliveira PJ, (2005) Cardiac mitochondrial alterations observed in hyperglycaemic rats-what can we learn from cell biology? Curr Diabetes Rev 1: 11-21.
41. Finegan BA, Lopaschuk GD, Gandhi M, Clanachan AS, (1995) Ischemic preconditioning inhibits glycolysis and proton production in isolated working rat hearts. Am J Physiol 269: H1767-H1775.
42. Halestrap AP, Clarke SJ, Khaliulin I, (2007) The role of mitochondria in protection of the heart by preconditioning. Biochim Biophys Acta 1767: 1007-1031 doi:10.1016/j.bbabio.2007.05.008.
43. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, et al. (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300: 1140-1142 doi:10.1126/science.1082889.
44. Pisarenko O, Studneva I, Khlopkov V, Solomatina E, Ruuge E, (1988) An assessment of anaerobic metabolism during ischemia and reperfusion in isolated guinea pig heart. Biochim Biophys Acta 934: 55-63.
45. Schroeder MA, Atherton HJ, Ball DR, Cole MA, Heather LC, et al. (2009) Real-time assessment of Krebs cycle metabolism using hyperpolarized 13C magnetic resonance spectroscopy. FASEB J 23: 2529-2538 doi:10.1096/fj.09-129171.
46. Taegtmeyer H, (1978) Metabolic responses to cardiac hypoxia. Increased production of succinate by rabbit papillary muscles. Circ Res 43: 808-815.
47. Ashrafian H, Czibik G, Bellahcene M, Aksentijević D, Smith AC, et al. (2012) Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway. Cell Metab 15: 361-371 doi:10.1016/j.cmet.2012.01.017.
48. Randle PJ, England PJ, Denton RM, (1970) Control of the tricarboxylate cycle and its interactions with glycolysis during acetate utilization in rat heart. Biochem J 117: 677-695.
49. Lesnefsky EJ, Chen Q, Moghaddas S, Hassan MO, Tandler B, et al. (2004) Blockade of electron transport during ischemia protects cardiac mitochondria. J Biol Chem 279: 47961-47967 doi:10.1074/jbc.M409720200.
50. Gaster M, (2009) Reduced TCA flux in diabetic myotubes: A governing influence on the diabetic phenotype? Biochem Biophys Res Commun 387: 651-655 doi:10.1016/j.bbrc.2009.07.064.
51. Bradamante S, Marchesani A, Barenghi L, Paracchini L, de Jonge R, et al. (2000) Glycogen turnover and anaplerosis in preconditioned rat hearts. Biochim Biophys Acta 1502: 363-379.
52. MacDonald MJ, Longacre MJ, Langberg E-C, Tibell A, Kendrick MA, et al. (2009) Decreased levels of metabolic enzymes in pancreatic islets of patients with type 2 diabetes. Diabetologia 52: 1087-1091 doi:10.1007/s00125-009-1319-6.
53. Ussher JR, Wang W, Gandhi M, Keung W, Samokhvalov V, et al. (2012) Stimulation of glucose oxidation protects against acute myocardial infarction and reperfusion injury. Cardiovasc Res 94: 359-369 doi:10.1093/cvr/cvs129.
54. Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, et al. (2003) Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem 278: 8516-8525 doi:10.1074/jbc.M210432200.
55. Sárközy M, Zvara A, Gyémánt N, Fekete V, Kocsis GF, et al. (2013) Metabolic syndrome influences cardiac gene expression pattern at the transcript level in male ZDF rats. Cardiovasc Diabetol 12: 16 doi:10.1186/1475-2840-12-16.
56. Lopaschuk GD, Wambolt RB, Barr RL, (1993) An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts. J Pharmacol Exp Ther 264: 135-144.
57. Hausenloy DJ, Yellon DM, (2007) Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev 12: 217-234 doi:10.1007/s10741-007-9026-1.
58. Leonard BL, Watson RN, Loomes KM, Phillips ARJ, Cooper GJ, (2005) Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes. Acta Diabetol 42: 162-170 doi:10.1007/s00592-005-0197-8.
59. Yakubu-Madus FE, Johnson WT, Zimmerman KM, Dananberg J, Steinberg MI, (1999) Metabolic and hemodynamic effects of moxonidine in the Zucker diabetic fatty rat model of type 2 diabetes. Diabetes 48: 1093-1100.
60. Bonen A, Holloway GP, Tandon NN, Han X-X, McFarlan J, et al. (2009) Cardiac and skeletal muscle fatty acid transport and transporters and triacylglycerol and fatty acid oxidation in lean and Zucker diabetic fatty rats. Am J Physiol Regul Integr Comp Physiol 297: R1202-R1212 doi:10.1152/ajpregu.90820.2008.